NYSE: TDOCTeladoc Health Inc Stock
$6.83-0.07 (-1.01%)
Updated Apr 17, 2025
TDOC Price
$6.83
Fair Value Price
N/A
Market Cap
$1.19B
52 Week Low
$6.61
52 Week High
$15.21
P/E
-1.16x
P/B
0.8x
P/S
0.6x
PEG
N/A
Dividend Yield
N/A
Revenue
$2.57B
Earnings
-$1.00B
Gross Margin
70.8%
Operating Margin
-37.74%
Profit Margin
-39%
Debt to Equity
1.36
Operating Cash Flow
$294M
Beta
1.5
Next Earnings
Apr 23, 2025
Ex-Dividend
N/A
Next Dividend
N/A
TDOC Overview
Teladoc Health Incorporated provides virtual healthcare services in the U.S. and internationally. Services and solutions address non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions. It also offers mental health solutions, and platform and program services. Teladoc Health was incorporated in 2002 and is headquartered in Purchase, NY.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine TDOC's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Health Information Service
Industry Rating
B
TDOC
Ranked#30 of 44
Ranked#30 of 44
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $149.00 | A | |
| $62.37 | A | |
| $1.42 | B |
Be the first to know about important TDOC news, forecast changes, insider trades & much more!
TDOC News
Overview
Due Diligence Score
–
Industry Average (25)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how TDOC scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
TDOC is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
TDOC is good value based on its book value relative to its share price (0.8x), compared to the US Health Information Services industry average (3.39x)
P/B vs Industry Valuation
TDOC is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more TDOC due diligence checks available for Premium users.
Valuation
TDOC price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-1.16x
Industry
11.14x
Market
27.98x
TDOC price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.8x
Industry
3.39x
TDOC is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
TDOC's financial health
Profit margin
Revenue
$640.5M
Net Income
-$48.4M
Profit Margin
-7.6%
TDOC's Earnings (EBIT) of -$969.85M... subscribe to Premium to read more.
Interest Coverage Financials
TDOC's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$3.5B
Liabilities
$2.0B
Debt to equity
1.36
TDOC's short-term assets ($1.66B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
TDOC's short-term assets ($1.66B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
TDOC's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
TDOC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$85.9M
Investing
-$29.6M
Financing
$2.1M
TDOC's operating cash flow ($293.68M)... subscribe to Premium to read more.
Debt Coverage Financials
TDOC vs Health Information Service Stocks
Teladoc Health Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.